Dilaudid is classified as a pregnancy category C drug by the U.S. Food and Drug Administration (FDA). Dilaudid is not recommended unless the benefits to the mother outweigh the risk to fetal development. Used to treat moderate to severe pain, Dilaudid is a narcotic pain reliever that can be habit forming. If pregnant or planning a pregnancy, consult a health care professional before taking Dilaudid.
- Dilaudid is a brand name for generic hydromorphone.
- Mothers who are breastfeeding or plan to breastfeed should consult with a physician to learn about the risks associated with Dilaudid.
- Studies have shown that Dilaudid can be excreted into the breast milk and cause addiction in infants. Signs of withdrawal include irritability, excessive crying, tremors, increased breathing rate, increased stools, sneezing, yawning, vomiting, and fever.